Cite
Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.
MLA
Avci, Nilufer, et al. “Neoadjuvant Chemotherapy-Induced Changes in Immunohistochemical Expression of Estrogen Receptor, Progesterone Receptor, HER2, and Ki-67 in Patients with Breast Cancer.” Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology, vol. 20, no. 1, Jan. 2015, pp. 45–49. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=25778295&authtype=sso&custid=ns315887.
APA
Avci, N., Deligonul, A., Tolunay, S., Cubukcu, E., Fatih Olmez, O., Ulas, A., Hartavi, M., Kurt, E., & Evrensel, T. (2015). Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer. Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology, 20(1), 45–49.
Chicago
Avci, Nilufer, Adem Deligonul, Sahsine Tolunay, Erdem Cubukcu, Omer Fatih Olmez, Arife Ulas, Mustafa Hartavi, Ender Kurt, and Turkkan Evrensel. 2015. “Neoadjuvant Chemotherapy-Induced Changes in Immunohistochemical Expression of Estrogen Receptor, Progesterone Receptor, HER2, and Ki-67 in Patients with Breast Cancer.” Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology 20 (1): 45–49. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=25778295&authtype=sso&custid=ns315887.